Variant report
Variant | esv2095219 |
---|---|
Chromosome Location | chr4:3618617-3619046 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574765029 | chr4:3618652-3618653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575613331 | chr4:3618666-3618667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112946341 | chr4:3618667-3618668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540877492 | chr4:3618678-3618679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs5855799 | chr4:3618679-3618680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568681101 | chr4:3618689-3618690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4259009 | chr4:3618694-3618695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs5855798 | chr4:3618727-3618728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534356397 | chr4:3618728-3618729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557185998 | chr4:3618736-3618737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147239079 | chr4:3618760-3618761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571085238 | chr4:3618761-3618762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5855797 | chr4:3618781-3618782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140803897 | chr4:3618785-3618786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540110390 | chr4:3618792-3618793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565563598 | chr4:3618795-3618796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532703901 | chr4:3618800-3618801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10937899 | chr4:3618809-3618810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535554821 | chr4:3618843-3618844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74544288 | chr4:3618852-3618853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374610444 | chr4:3618859-3618860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200140293 | chr4:3618883-3618884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115774726 | chr4:3618886-3618887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368430941 | chr4:3618895-3618896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530352001 | chr4:3618902-3618903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10937900 | chr4:3618920-3618921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76075794 | chr4:3618921-3618922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115853015 | chr4:3618940-3618941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151091529 | chr4:3618967-3618968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10937901 | chr4:3618975-3618976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371864831 | chr4:3618984-3618985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111216228 | chr4:3619004-3619005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111065374 | chr4:3619017-3619018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111064817 | chr4:3619033-3619034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Ependymoma | 20639864 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3615600-3619600 | Enhancers | Fetal Brain Male | brain |